These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35603888)

  • 1. The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study.
    Ring HC; Yao Y; Maul JT; Ingram JR; Frew JW; Thorsen J; Nielsen ML; Wu JJ; Thyssen JP; Thomsen SF; Egeberg A
    Br J Dermatol; 2022 Oct; 187(4):523-530. PubMed ID: 35603888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy.
    Vural S; Gündoğdu M; Akay BN; Boyvat A; Erdem C; Koçyiğit P; Bostancı S; Sanli H; Kundakci N
    Dermatol Ther; 2019 Sep; 32(5):e13003. PubMed ID: 31237104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review.
    Blok JL; van Hattem S; Jonkman MF; Horváth B
    Br J Dermatol; 2013 Feb; 168(2):243-52. PubMed ID: 23106519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis suppurativa in children and young adults: a retrospective cross-sectional observational study in the United Kingdom.
    McGrath C; Steyn M; Rashidghamat E
    Int J Dermatol; 2024 Jul; 63(7):904-906. PubMed ID: 38273707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on Medical Treatment Options for Hidradenitis Suppurativa.
    Deckers IE; Prens EP
    Drugs; 2016 Feb; 76(2):215-29. PubMed ID: 26659474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Survival of Biologics in Patients With Hidradenitis Suppurativa.
    Ring HC; Maul JT; Yao Y; Wu JJ; Thyssen JP; Thomsen SF; Egeberg A
    JAMA Dermatol; 2022 Feb; 158(2):184-188. PubMed ID: 34851360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
    Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
    Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic Treatment for Hidradenitis Suppurativa.
    Flood KS; Porter ML; Kimball AB
    Am J Clin Dermatol; 2019 Oct; 20(5):625-638. PubMed ID: 31140067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
    Scheinfeld N
    Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
    Mendonça CO; Griffiths CE
    Br J Dermatol; 2006 May; 154(5):977-8. PubMed ID: 16634904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study.
    Bouwman K; Aarts P; Dudink K; Hao J; Alizadeh BZ; Prens LM; Vossen ARJV; van Straalen KR; van der Zee HH; Horváth B
    Am J Clin Dermatol; 2022 Nov; 23(6):905-914. PubMed ID: 36070059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.
    Scheinfeld N
    Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shorter time to initiation of biologic therapy in the setting of a hidradenitis suppurativa specialty clinic.
    Kearney N; O'Donohoe S; Hughes R; Kirby B
    Clin Exp Dermatol; 2023 Sep; 48(10):1149-1151. PubMed ID: 37256275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
    Dessinioti C; Zisimou C; Tzanetakou V; Stratigos A; Antoniou C
    Clin Exp Dermatol; 2016 Dec; 41(8):852-857. PubMed ID: 27753139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic treatment of moderate/severe hidradenitis suppurativa].
    Pinter A; Mrowietz U; Volz T
    Hautarzt; 2021 Aug; 72(8):686-691. PubMed ID: 34189590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review.
    Molinelli E; Gioacchini H; Marani A; Rizzetto G; Gambini D; De Simoni E; Offidani A; Simonetti O
    Dermatol Ther (Heidelb); 2024 May; 14(5):1079-1091. PubMed ID: 38700645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.